Sage Capital Advisors’s Zimmer Biomet ZBH Stock Holding History

Sage Capital Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,703	Closed	-$1.06M	–	145
2026 Q1	$1.06M	Buy	11,703 +1	+0%	+$92	0.25%	73
2025 Q4	$1.05M	Buy	11,702 +2,502	+27%	+$237K	0.25%	71
2025 Q3	$906K	Buy	+9,200	New	+$912K	0.22%	74
2017 Q4	–	Sell	-18,086	Closed	-$2.06M	–	91
2017 Q3	$2.06M	Sell	18,086 -306	-2%	-$35.3K	1.44%	25
2017 Q2	$2.29M	Buy	+18,392	New	+$2.18M	1.68%	24

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Sage Capital Advisors's ZBH Position: Q2 2026 in Review

Sage Capital Advisors sold out of Zimmer Biomet (ZBH) in Q2 2026, closing a stake of 11,703 shares — an estimated $1.06M sold.

Sage Capital Advisors first reported a position in ZBH in Q2 2017 and held it in 5 quarters. The position peaked at $2.29M in Q2 2017. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Sage Capital Advisors reported no remaining Zimmer Biomet position as of Q2 2026 after selling out during the quarter.
Sage Capital Advisors sold 11,703 Zimmer Biomet shares in Q2 2026, an estimated $1.06M.
Sage Capital Advisors first reported a position in Zimmer Biomet in Q2 2017 and held it in 5 quarters.
Sage Capital Advisors's Zimmer Biomet position peaked at $2.29M in Q2 2017.
906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Sage Capital Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.